✦ LIBER ✦

A randomised, double-blind, placebo-controlled, crossover study to assess the efficacy and safety of three dosing schedules of agalsidase alfa enzyme replacement therapy for Fabry disease

✍ Scribed by Hughes, D.A.; Deegan, P.B.; Milligan, A.; Wright, N.; Butler, L.H.; Jacobs, A.; Mehta, A.B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open-label, switchover trial to asses

✍ Richards, Sarah; Laney, Dawn; Pervaiz, Muhammad A.; Shankar, Suma 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 62 KB

A double-blind, randomised- placebo, con

✍ Choi, H K; Ahn, T Y; Kim, J J; Kim, S C; Paick, J S; Suh, J K; Kim, H S; Kim, Y 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 183 KB

A double-blind, placebo-controlled, rand

✍ Santiago Perez Lloret; Gabriela Nano; Andrea Carrosella; Elkan Gamzu; Marcelo Me 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Efficacy and safety of adding the dipept

✍ M. A. Nauck; G. C. Ellis; P. R. Fleck; C. A. Wilson; Q. Mekki; for the Aloglipti 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

80* A randomised, double-blind, placebo-

✍ J.S. Elborn; A. Sharma; Q. Deng; P. Koker 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 51 KB